What is it about?
The development of light-inducible systems has allowed us to control single signalling molecules with incredible precision. Now, we can combine this precision to the discovery of drug-target interactions, by activating or inhibiting certain pathways that are the expected drug targets. We can use these systems to rescue signalling and thus pin-point the actual targeting molecule.
Featured Image
Why is it important?
This is a new point of view to increase the accuracy and understand drug targeting. Moreover, it can speed up the long and tenuous drug discovery pipeline.
Perspectives
Read the Original
This page is a summary of: Optogenetics in cancer drug discovery, Expert Opinion on Drug Discovery, February 2018, Taylor & Francis,
DOI: 10.1080/17460441.2018.1437138.
You can read the full text:
Contributors
The following have contributed to this page